Five patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2029. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Dec 2029
Next term end
2
Patent families
When these terms end
Each bar runs from grant to computed term end. 2019 to 2038.
US 12,663,429
Cartridge Device for a Measuring System for Measuring Viscoelastic Characteristics of a Sample Liquid, a Corresponding Measuring System, and a Corresponding Method
no later than Dec 17, 2029
20232027203120352038
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
1 pending application: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Mar 2037 · High confidence
Also notable
Ends no later than Dec 2029 · Low confidence
Blood Testing System and Method
US 10,175,225
The most cited patent in this portfolio, cited by 53 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2037.
Cartridge Device for a Measuring System for Measuring Viscoelastic Characteristics of a Sample Liquid, a Corresponding Measuring System, and a Corresponding Method
US 12,663,429
A family of 12 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 8, 2027The maintenance fee for Blood Testing System and Method (US 11,719,688) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,663,429 | Cartridge Device for a Measuring System for Measuring Viscoelastic Characteristics of a Sample Liquid, a Corresponding Measuring System, and a Corresponding Method In force · Low confidence | In force | Low confidence | |
| US 11,327,069 | Blood Testing System and Method In force · High confidence | In force | High confidence | |
| US 11,719,688 | Blood Testing System and Method In force · High confidence | In force | High confidence | |
| US 10,175,225 | Blood Testing System and Method In force · High confidence | In force | High confidence | |
| US 12,578,349 | Blood Testing System and Method In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 5: 1 application pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed